APA 6th Edition Jukić, T., Punda, M., Franceschi, M., Staničić, J., Granić, R. i Kusić, Z. (2015). AMIODARON I FUNKCIJA ŠTITNJAČE. Liječnički vjesnik, 137 (5-6), 0-0. Preuzeto s https://hrcak.srce.hr/172706
MLA 8th Edition Jukić, Tomislav, et al. "AMIODARON I FUNKCIJA ŠTITNJAČE." Liječnički vjesnik, vol. 137, br. 5-6, 2015, str. 0-0. https://hrcak.srce.hr/172706. Citirano 27.01.2020.
Chicago 17th Edition Jukić, Tomislav, Marija Punda, Maja Franceschi, Josip Staničić, Roko Granić i Zvonko Kusić. "AMIODARON I FUNKCIJA ŠTITNJAČE." Liječnički vjesnik 137, br. 5-6 (2015): 0-0. https://hrcak.srce.hr/172706
Harvard Jukić, T., et al. (2015). 'AMIODARON I FUNKCIJA ŠTITNJAČE', Liječnički vjesnik, 137(5-6), str. 0-0. Preuzeto s: https://hrcak.srce.hr/172706 (Datum pristupa: 27.01.2020.)
Vancouver Jukić T, Punda M, Franceschi M, Staničić J, Granić R, Kusić Z. AMIODARON I FUNKCIJA ŠTITNJAČE. Liječnički vjesnik [Internet]. 2015 [pristupljeno 27.01.2020.];137(5-6):0-0. Dostupno na: https://hrcak.srce.hr/172706
IEEE T. Jukić, M. Punda, M. Franceschi, J. Staničić, R. Granić i Z. Kusić, "AMIODARON I FUNKCIJA ŠTITNJAČE", Liječnički vjesnik, vol.137, br. 5-6, str. 0-0, 2015. [Online]. Dostupno na: https://hrcak.srce.hr/172706. [Citirano: 27.01.2020.]
Sažetak Amiodarone is a benzofuran derivative that contains up to 40% of iodine. Amiodarone is used for treatment and prevention of life threatening supraventricular and ventricular tachyarrhythmias. The effects on thyroid gland vary from abnormalities in thyroid function tests to overt amiodarone induced hypothyroidism (AIH) and thyrotoxicosis (AIT). Patients with AIH are treated with L-thyroxine and may continue treatment with amiodarone. Two different forms of AIT have to be distinguished: amiodarone induced hyperthyroidism (AIT I) and thyroiditis (AIT II). AIT I is treated with antithyroid drugs, while total thyroidectomy and iodine-131 are used for definitive treatment. AIT II is treated with glucocorticoids. Patients with AIT have to stop treatment with amiodarone. Dronedarone is a less potent antiarrhythmic agent with structural and pharmacological properties similar to amiodarone. Dronedarone is devoid of iodine with fewer adverse effects and therefore it may be used in high risk patients for development of AIT or AIH.